Description: Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses. The company provides Osseointegrated Prostheses for the Rehabilitation of Amputees (OPRA) implant systems, a bone-anchored prostheses system based on osseointegration, where the prostheses are directly attached to the bone, avoiding the use of socket. The OPRA implant system offers protection to the patient by avoiding bone fractures from accidental loads. The company also provides Neuromotus, a technology that is used for therapy to reduce phantom limb pain after an amputation. It sells its implant systems to hospitals, clinics, and orthopedists worldwide. The company was founded in 1962 and is headquartered in Mölndal, Sweden.
Home Page: www.integrum.se
Krokslätts Fabriker 50
Mölndal,
431 37
Sweden
Phone:
46 3 17 60 10 60
Officers
| Name | Title |
|---|---|
| Dr. Rickard Branemark | Owner, Director, Chief Scientific Officer & CEO |
| Mr. Dennis Baecklund | Chief Financial Officer |
| Mr. James Sheridan | Head of Sales & Marketing of EMEA |
| Mr. Thomas J. Dugan | Pres of US |
| Ms. Karin Ganlöv M.D. | Chief Medical Officer |
| Ms. Anna-Tove Branemark | Chief Exec. Officer of Integrum Inc. |
Exchange: ST
Country: SE
Currency: Swedish krone (kr)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 181.75 |
| Price-to-Book MRQ: | 4.491 |
| Price-to-Sales TTM: | 8.7133 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 31 |